Abstract
Astaxanthin alleviates hepatic lipid accumulation and peroxidation, inflammation, and fibrosis in mice with high-cholesterol, high-cholate, and high-fat (CL) diet-induced nonalcoholic steatohepatitis (NASH) [...].
Keywords:
astaxanthin; comprehensive gene expression analysis; eukaryotic initiation factor-2 (EIF2); nonalcoholic steatohepatitis (NASH); peroxisome proliferator-activated receptor α (PPARA); vitamin E.
MeSH terms
-
Animals
-
Diet, High-Fat / adverse effects
-
Disease Models, Animal
-
Eukaryotic Initiation Factor-2 / metabolism
-
Gene Expression Profiling
-
Liver / drug effects*
-
Liver / metabolism*
-
Male
-
Mice
-
Mitochondria / drug effects
-
Mitochondria / genetics
-
Mitochondria / metabolism
-
Non-alcoholic Fatty Liver Disease / drug therapy
-
Non-alcoholic Fatty Liver Disease / etiology*
-
Non-alcoholic Fatty Liver Disease / metabolism*
-
Non-alcoholic Fatty Liver Disease / pathology
-
PPAR alpha / metabolism
-
PPAR delta / metabolism
-
Protein Interaction Mapping
-
Protein Interaction Maps
-
Retinoic Acid Receptor alpha / metabolism
-
Signal Transduction / drug effects
-
Transcriptome*
-
Vitamin E / pharmacology*
-
Xanthophylls / pharmacology
Substances
-
Eukaryotic Initiation Factor-2
-
PPAR alpha
-
PPAR delta
-
Retinoic Acid Receptor alpha
-
Xanthophylls
-
Vitamin E
-
astaxanthine